TOBI Podhaler (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the TOBI Podhaler drug offered from Novartis Pharmaceuticals Corporation. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Tobramycin |
| SUBSTANCE NAME: | TOBRAMYCIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
| ROUTE: | ORAL; RESPIRATORY (INHALATION) |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-03-22 |
| END MARKETING DATE: | 0000-00-00 |
TOBI Podhaler HUMAN PRESCRIPTION DRUG Details:
| Item Description | TOBI Podhaler from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 28(mg/1) |
| START MARKETING DATE: | 2013-03-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0630_77a25aa9-d445-4568-a3cb-9b9cd9974dee |
| PRODUCT NDC: | 0078-0630 |
| APPLICATION NUMBER: | NDA201688 |
Other TOBRAMYCIN Pharmaceutical Manufacturers / Labelers:
